The $2 billion Norwest Venture Partners XV will target early- to late-stage companies disrupting the healthcare, consumer and enterprise sectors. The new fund follows the early 2018 close of a $1.5 billion fund, and brings the firm’s total funding to more than $9.5 billion.
In the last two years, the firm’s portfolio has seen almost 50 new investments, as well as 23 IPOs and several portfolio company acquisitions. Recent exits include Health Catalyst, which went public in July, and Silk Road Medical, which did so in April; beyond healthcare, Norwest Venture Partners has also counted Uber, Spotify and Adaptive Insights among its portfolio companies before their own exits or acquisitions.
More articles on health IT:
Internal and external investments are equally crucial for an innovation ecosystem
Warren vows to conduct antitrust investigation of EHR market
Mayo Clinic study finds AI-powered stethoscope detects heart failure at point of care
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
